Filing Details

Accession Number:
0001593968-15-000033
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-02-11 21:32:23
Reporting Period:
2015-02-10
Filing Date:
2015-02-11
Accepted Time:
2015-02-11 21:32:23
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
749660 Icad Inc ICAD Surgical & Medical Instruments & Apparatus (3841) 020377419
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1362512 M Stacey Stevens 98 Spit Brook Rd. Ste. 100
Nashua NH 03062
Svp Marketing &Amp; Strategy No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-02-10 17,298 $5.75 105,029 No 4 M Direct
Common Stock Disposition 2015-02-10 17,298 $10.00 87,731 No 4 S Direct
Common Stock Acquisiton 2015-02-10 10,000 $5.10 97,731 No 4 M Direct
Common Stock Disposition 2015-02-10 10,000 $10.00 87,731 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Option (right to buy) Disposition 2015-02-10 17,298 $0.00 17,298 $5.75
Common Stock Option (right to buy) Disposition 2015-02-10 10,000 $0.00 10,000 $5.10
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2012-03-29 2021-03-29 No 4 M Direct
10,000 2012-07-08 2021-07-08 No 4 M Direct
Footnotes
  1. The reported securities were executed in multiple trades with prices ranging between $10.00 and $10.01. The reporting person hereby undertakes to provide, upon request, to the SEC Staff, the Issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected.
  2. This sale is made pursuant to a trading plan previously entered into by the reporting person and complies with the requirements of Rule 10b5-1(c)(1) under the Securities Exchange Act of 1934, as amended.